课题基金 / 基金详情

transgenic expression of UPRT as a novel tool for tagging RNA in specific tissues of the mouse

transgenic expression of UPRT as a novel tool for tagging RNA in specific tissues of the mouse
UPRT 的转基因表达作为在小鼠特定组织中标记 RNA 的新工具
批准号:
BB/K013424/1
负责人:
Martin Turner
金额:
$13.98万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --

项目摘要

项目成果

Martin Turner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary (Lay)RNA is synthesised using information encoded by DNA and it mediates many of the functions of the genome as well as producing proteins. Understanding the regulation of RNA is a priority for the understanding of cell function. Like DNA sequences, RNA sequences are made up for four bases, but, unlike DNA, RNA contains the nucleoside uridine which is composed of the pyrimidine uracil. Uracil is not incorporated into the RNA of mouse or human cells as the required enzymes for this pathway are not encoded in the mammalian genome. Consequently, controlled expression of the enzyme uracil phosphoribosyltransferase (UPRT) which converts uracil into uridine monophosphate allows the incorporation of uracil in cell-type specific or temporally controlled manner labelling of RNA. We have generated a transgenic mouse that expresses UPRT in a controllable way and we want to demonstrate the broad utility of this as a tool for purification of RNA or the identification of RNA protein interactions in rare cell subsets in complex mixtures of cells. This is an improvement because it will open access to the RNA makeup of some cell types that cannot be easily purified. Furthermore, the act of purification is known to change the quantity and quality of the RNA within the cell. Thus by reducing the numbers of manipulations a more accurate readout of RNA content or RNA-protein interactions will be obtained.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms restraining the accumulation of antibody secreting cells
  • 批准号:
    BB/W015242/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $95.83万
  • 财政年份:
    2023
  • 负责人:
    Martin Turner
  • 依托单位:
PTBP proteins in T cell activation: Cellular and molecular mechanisms of action
  • 批准号:
    BB/P01898X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $95.79万
  • 财政年份:
    2017
  • 负责人:
    Martin Turner
  • 依托单位:
Testing the Mechanism of T lymphocyte selection in the thymus mediated by the zfp36 family of RNA binding proteins
  • 批准号:
    MR/N010434/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $47.72万
  • 财政年份:
    2016
  • 负责人:
    Martin Turner
  • 依托单位:
Dissecting the molecular mechanisms of PI3K in Extra-Follicular Helper and Regulatory T cell differentiation
  • 批准号:
    BB/M021343/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $49.74万
  • 财政年份:
    2015
  • 负责人:
    Martin Turner
  • 依托单位:
国内基金
海外基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张明
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
  • 批准号:
    82370906
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    代杰文
  • 依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈颖
  • 依托单位: